GlassScriptPhysician profile
David L Sobel
NPI 1811974736
$3,570.53
in general payments reported to CMS, 2019-2025
22 companies · $810 in 2025
The $810 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,194 · 2020: $14.00 · 2021: $682 · 2022: $155 · 2023: $365 · 2024: $352 · 2025: $810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,525.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $925.03 | 2019-2020 | |
| Boston Scientific Corporation | $365.24 | 2019-2025 | Axonics, Spaceoar Vue System - 10ml |
| Teleflex LLC | $363.14 | 2021-2025 | Urolift, Barrigel |
| Myovant Sciences INC. | $317.36 | 2021-2022 | |
| Procept Biorobotics Corporation | $299.64 | 2024-2025 | Aquabeam System |
| Medtronic, INC. | $242.57 | 2022-2023 | Interstim |
| Srs Medical Systems, INC. | $166.56 | 2025 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Axonics, INC. | $153.45 | 2022-2024 | Axonics, Bulkamid |
| Coloplast Corp | $150.70 | 2019-2023 | Titan |
| Endo Pharmaceuticals INC. | $118.63 | 2019 | |
| Palette Life Sciences, INC. | $115.90 | 2021 | |
| Olympus America INC. | $82.43 | 2023-2025 | Itind System |
| Astellas Pharma US INC | $44.99 | 2019 | |
| Laborie Medical Technologies Corp. | $41.33 | 2023 | |
| Innovation Technologies INC | $36.67 | 2025 | Irrisept |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abc Home Medical Supply, INC. | $29.58 | 2023 | |
| Janssen Biotech, INC. | $27.90 | 2025 | Erleada |
| Sumitomo Pharma America, INC. | $22.99 | 2023 | Orgovyx |
| 180 Medical, INC. | $22.58 | 2024 | |
| Mimedx Group, INC. | $16.07 | 2025 | |
| Myriad Genetic Laboratories, INC. | $15.50 | 2025 | Prolaris |
| Avion Pharmaceuticals | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sobel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.